Need help finding what you are looking for?
Contact Us
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1931745
PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1931745
Microfluidics Market by Product (Chip, Sensor, Valve, Pump, Needle), Material (Silicon, Polymer), Application, End User - Global forecast to 2030
PUBLISHED:
PAGES: 326 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The Microfluidics market is projected to reach USD 37.2 Billion by 2030 from USD 24.96 billion in 2025, growing at a CAGR of 8.3% during the forecast period. The microfluidics market is expanding due to a number of important factors. The growing requirement for point-of-care diagnostics is one of the important factors. The necessity for fast and accurate diagnosis has risen due to the increase in chronic diseases like cancer and diabetes, which is propelling the application of microfluidics in healthcare.
| Scope of the Report | |
|---|---|
| Years Considered for the Study | 2024-2030 |
| Base Year | 2024 |
| Forecast Period | 2025-2030 |
| Units Considered | Value (USD billion) |
| Segments | Product, Application, End User, and Region |
| Regions covered | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Furthermore, the use of microfluidic devices is increasing due to innovations in drug delivery, organ-on-a-chip technology, and personalized medicine. Additionally, the market is driven by the rise in proteomics and genomics-associated research.
"Polymers to account for the largest market share in 2024."
The microfluidics market is propelled by polymers because of their low costs, ease of production and adaptability. Microfluidic device manufacturing often requires polymers such as polydimethylsiloxane (PDMS), polymethyl methacrylate (PMMA), and cyclic olefin copolymer (COC). These polymers are helpful in the fabrication of microfluidic channels and structures. Moreover, as compared to conventional materials like silicon or glass, polymers are easier to mold and also enable cheaper manufacturing costs. The biocompatible property of polymers makes them useful for a variety of medical applications, including medication delivery, lab-on-a-chip, and diagnostics. Due to such advantages, polymers account for the largest share in the microfluidics market.
"Hospital and Diagnostic Centers to register the highest growth rate in the market during the forecast period."
Various significant factors are propelling the growth of hospitals and diagnostic centers in the microfluidics industry. One important factor is the rising requirement for point-of-care diagnostics, as they provides quick, on-site testing that improves patient outcomes. Microfluidics play a major role in this positive outcome as it offers faster and precise result . Moreover, the requirement for efficacious diagnostics in clinical settings has risen due to the increase in infectious diseases like COVID-19. These equipment decreases cost, expedites testing methods, and improve precision and accuracy of diagnosis.
"Asia Pacific to register highest growth rate in the market during the forecast period."
The highest CAGR was recorded in the APAC region during the forecast period of 2024- 2029. Asia Pacific includes India, China, Japan, Australia, South Korea, and RoAPAC. Demand for novel technologies is also on the rise, particularly in China, India, and Japan. The government is striving hard to develop research activities in academic setups. In this regard, the Japanese government has distributed USD 64.26 billion toward its 6th Science and Technology Basic Plan for 2021-2025. The rising incidence of chronic and infectious diseases, coupled with increased interest in early diagnosis and preventive care, has enhanced the utilization of microfluidic devices by tremendous bounds. The pharmaceutical and life sciences sectors, which are fast growing in the region, are also driving the research and development efforts, hence increasing the demand for microfluidics.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1-30%, Tier 2-42%, and Tier 3- 28%
- By Designation: C-level-- 10%, Director-level-14%, and Others-76%
- By Region: North America-40%, Europe-30%, Asia Pacific-22%, Rest of the World -8%.
Prominent players in this market are Abbott laboratories (US) , Agilent Technologies, Inc. (US), Aignep S.P.A (Italy), biomerieux (France), BD(US), Bio-Rad laboratories, Inc (US), Danaher Corporation (US), Illumina Inc. (US), Parker Hannifin Corporation (US), Thermo Fisher Scientific Inc. (US), SMC Corporation (Japan), Idex Corporation (US), Fortive Corporation (US), Perkinelmer, Inc. (US), F.Hoffmann-LA Roche Ltd (Switzerland), Standard Biotools Inc. (US), Quidelortho Corporation (US), Hologic Inc. (US), Dolomite Microfluidics (UK) and Elveflow (France).
Research Coverage
The report comprise segmentation that covers end users, products, applications, and geographic regions. It also covers the key drivers, restraints, opportunities, and challenges impacting the growth trajectory of the microfluidics market. The research offers stakeholders an in-depth analysis of market potential and challenges, with a focus on major players and competitive landscapes. Moreover, micromarkets are analysed as per their overall impact to the global microfluidics sector, growth patterns, and potential. The analysis forecasts rise in market segment revenues, focusing on five key regions.
Key Benefits of Buying the Report:
The purpose of this research is to assist both new and existing players in the microfluidics market to assess the sustainability of their investments by providing detailed and knowledgeable information. It offers a dataset to assist in making key decisions. This report's potential to facilitate thorough risk evaluation and provide direction for investment decisions is one of its major benefit. Market segmentation according to end-users and geographical areas is provided in the study, that provides precise analysis and insights. It also provide significant trends, obstacles, opportunities, and drivers, giving stakeholders the information they require to make strategic decisions that help in their long-term growth.
The report provides the insights on the following pointers:
Analysis of the key drivers, restraints, opportunities, and challenges affecting the microfluidics market growth: Innovative technology and increase in prevalence of chronic diseases ; increased cost of devices and stringent regulations ; increase in number of diagnostic centers.
Product Development/Innovation: Overview of technologies, research & development ventures and launch of innovative product & service for the microfluidics industry.
Market Development: Details associated with profitable markets: this research studies the microfluidics business in various geographical regions.
Market Diversification: In-depth understanding of innovative products, unexamined regions, recent developments, and expenditures in the microfluidics market.
Competitive Assessment: Detailed analysis of market share, services and products offered and key strategies adopted by prominent players such as Danaher Corporation (US), Illumina Inc. (US), biomerieux (France), Thermo Fisher Scientific Inc. (US) and Abbott laboratories (US).
Product Code: AST 7541
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 STUDY OBJECTIVES
- 1.2 MARKET DEFINITION
- 1.2.1 INCLUSIONS AND EXCLUSIONS
- 1.3 STUDY SCOPE
- 1.3.1 MARKET COVERED
- 1.3.2 YEARS CONSIDERED
- 1.4 CURRENCY CONSIDERED
- 1.5 STAKEHOLDERS
- 1.6 SUMMARY OF CHANGES
2 EXECUTIVE SUMMARY
- 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
- 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
- 2.3 DISRUPTIVE TRENDS IN MICROFLUIDICS MARKET
- 2.4 HIGH GROWTH SEGMENTS
3 PREMIUM INSIGHTS
- 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MICROFLUIDICS MARKET
- 3.2 MICROFLUIDICS MARKET, BY REGION
- 3.3 MICROFLUIDICS MARKET, BY COUNTRY AND END USER
- 3.4 GEOGRAPHIC SNAPSHOT OF MICROFLUIDICS MARKET
4 MARKET OVERVIEW
- 4.1 INTRODUCTION
- 4.2 MARKET DYNAMICS
- 4.2.1 DRIVERS
- 4.2.1.1 Integration of microfluidics with 3D printing
- 4.2.2 E-HEALTH AND DIGITAL DIAGNOSTICS DRIVING MICROFLUIDICS ADOPTION
- 4.2.2.1 Increasing prevalence of chronic diseases fueling POC testing
- 4.2.2.2 Increasing focus on data precision and accuracy
- 4.2.3 RESTRAINTS
- 4.2.3.1 Regulatory and clinical validation barriers
- 4.2.3.2 Material selection for microfluidic devices
- 4.2.4 OPPORTUNITIES
- 4.2.4.1 Advancing microfluidics for real-time food safety monitoring
- 4.2.4.2 Rising demand for organ-on-a-chip platforms in precision medicine
- 4.2.5 CHALLENGES
- 4.2.5.1 Limited adoption of microfluidic devices
- 4.2.5.2 Technical and operational limitations
- 4.2.1 DRIVERS
- 4.3 UNMET NEEDS
- 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
- 4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS
5 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, AND AI ADOPTION
- 5.1 KEY TECHNOLOGIES
- 5.1.1 MICROFABRICATION
- 5.1.2 MATERIAL SCIENCE
- 5.1.3 OPTOFLUIDICS
- 5.2 COMPLEMENTARY TECHNOLOGIES
- 5.2.1 MICRO-ELECTRO-MECHANICAL SYSTEMS (MEMS)
- 5.2.2 WEARABLE & IMPLANTABLE MICROFLUIDICS
- 5.3 PATENT ANALYSIS
- 5.3.1 INNOVATIONS AND PATENT REGISTRATIONS
- 5.4 FUTURE APPLICATIONS
- 5.5 IMPACT OF AI/GENAI ON MICROFLUIDICS MARKET
- 5.5.1 TOP USE CASES AND MARKET POTENTIAL
- 5.5.2 BEST PRACTICES IN MICROFLUIDICS
- 5.5.3 CASE STUDIES OF AI IMPLEMENTATION IN MICROFLUIDICS MARKET
- 5.5.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS
- 5.5.5 CLIENT'S READINESS TO ADOPT GENERATIVE AI IN MICROFLUIDICS MARKET
- 5.6 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
- 5.7 REGULATORY LANDSCAPE
- 5.7.1 NORTH AMERICA
- 5.7.1.1 US
- 5.7.1.2 Canada
- 5.7.2 EUROPE
- 5.7.3 ASIA PACIFIC
- 5.7.3.1 Japan
- 5.7.3.2 China
- 5.7.3.3 India
- 5.7.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.7.1 NORTH AMERICA
6 CUSTOMER LANDSCAPE & BUYER BEHAVIOR
- 6.1 BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
- 6.1.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 6.1.2 BUYING CRITERIA
- 6.2 DECISION-MAKING PROCESS
- 6.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
- 6.4 UNMET NEEDS FROM END USERS
7 INDUSTRY TRENDS
- 7.1 PORTER'S FIVE FORCES ANALYSIS
- 7.1.1 THREAT OF NEW ENTRANTS
- 7.1.2 THREAT OF SUBSTITUTES
- 7.1.3 BARGAINING POWER OF SUPPLIERS
- 7.1.4 BARGAINING POWER OF BUYERS
- 7.1.5 INTENSITY OF COMPETITIVE RIVALRY
- 7.2 MACROECONOMIC INDICATORS
- 7.2.1 INTRODUCTION
- 7.2.2 HEALTHCARE EXPENDITURE AND INFRASTRUCTURE OUTLOOK
- 7.2.3 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 7.2.4 MACROECONOMIC OUTLOOK FOR EUROPE
- 7.2.5 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 7.2.6 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 7.2.7 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 7.2.8 TRENDS IN GLOBAL MICROFLUIDICS INDUSTRY
- 7.3 VALUE CHAIN ANALYSIS
- 7.3.1 RESEARCH & DEVELOPMENT
- 7.3.2 RAW MATERIAL PROCUREMENT & MANUFACTURING
- 7.3.3 MARKETING & SALES, DISTRIBUTION, AND POST-SALES SERVICES
- 7.4 ECOSYSTEM ANALYSIS
- 7.5 PRICING ANALYSIS
- 7.5.1 AVERAGE SELLING PRICE TREND, BY REGION
- 7.5.2 AVERAGE SELLING PRICE OF MICROFLUIDIC COMPONENTS, BY KEY PLAYERS
- 7.6 TRADE DATA ANALYSIS
- 7.6.1 IMPORT DATA (HS CODE 3822)
- 7.6.2 EXPORT DATA (HS CODE 3822)
- 7.7 KEY CONFERENCES & EVENTS, 2026-2027
- 7.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
- 7.9 INVESTMENT & FUNDING SCENARIO
- 7.10 CASE STUDY ANALYSIS
- 7.10.1 CASE STUDY 1: MULTIPLEX MICROFLUIDIC CIRCUIT FOR BLOOD VESSEL-ON-A-CHIP PERFUSION USING FLOWEZ
- 7.10.2 CASE STUDY 2: MICROFLUIDIC SYSTEM FOR ROBOTIC HAND PLAYING NINTENDO
- 7.10.3 CASE STUDY 3: 3D-PRINTED MICROFLUIDIC DEVICES USING POLYJET TECHNOLOGY
- 7.11 IMPACT OF 2025 US TARIFFS ON MICROFLUIDICS MARKET
- 7.11.1 INTRODUCTION
- 7.11.2 KEY TARIFF RATES
- 7.11.3 PRICE IMPACT ANALYSIS
- 7.11.4 IMPACT ON COUNTRY/REGION
- 7.11.5 IMPACT ON END-USE INDUSTRIES
8 MICROFLUIDICS MARKET, BY PRODUCT
- 8.1 INTRODUCTION
- 8.2 MICROFLUIDICS-BASED DEVICES
- 8.2.1 HIGH UPTAKE OF POC TESTING AND ORGAN-ON-A-CHIP SYSTEMS TO DRIVE MARKET
- 8.2.2 POLYMERASE CHAIN REACTION (PCR) SYSTEMS
- 8.2.3 MICROFLUIDIC CAPILLARY ELECTROPHORESIS
- 8.2.4 NEXT-GENERATION SEQUENCING (NGS) SYSTEMS
- 8.2.5 DROPLET & PARTICLE PRODUCTION SYSTEMS
- 8.3 OTHER DEVICES
- 8.4 MICROFLUIDIC COMPONENTS
- 8.4.1 CRUCIAL FOR CONTINUOUS HEALTH MONITORING
- 8.4.2 MICROFLUIDIC COMPONENTS, BY TYPE
- 8.4.2.1 Microfluidic chips
- 8.4.2.2 Flow & pressure sensors
- 8.4.2.3 Flow & pressure controllers
- 8.4.2.4 Microfluidic valves
- 8.4.2.5 Micropumps
- 8.4.2.6 Microneedles
- 8.4.2.7 Other microfluidic components
- 8.4.3 MICROFLUIDIC COMPONENTS, BY MATERIAL
- 8.4.3.1 Silicon
- 8.4.3.2 Polymethyl methacrylate (PMMA)
- 8.4.3.3 Polydimethylsiloxane (PDMS)
- 8.4.3.4 Cyclic olefin copolymer (COC)
- 8.4.3.5 Glass
- 8.4.3.6 OTHER MATERIALS
9 MICROFLUIDICS MARKET, BY APPLICATION
- 9.1 INTRODUCTION
- 9.2 IN VITRO DIAGNOSTICS (IVD)
- 9.2.1 CLINICAL DIAGNOSTICS
- 9.2.1.1 Growing focus on early disease detection to drive market
- 9.2.2 POINT-OF-CARE TESTING (POCT)
- 9.2.2.1 Increasing demand for decentralized infectious disease testing to drive market
- 9.2.3 VETERINARY DIAGNOSTICS
- 9.2.3.1 Rising demand for rapid, field-deployable veterinary diagnostics to drive market
- 9.2.1 CLINICAL DIAGNOSTICS
- 9.3 THERAPEUTICS
- 9.3.1 DRUG DELIVERY
- 9.3.1.1 Ability to enable scalable production of polymer-based drug particles to drive market
- 9.3.2 WEARABLE
- 9.3.2.1 Ability to enable proactive management of hydration, metabolic status, and disease biomarkers to drive market
- 9.3.1 DRUG DELIVERY
- 9.4 PHARMACEUTICAL & LIFE SCIENCE RESEARCH
- 9.4.1 LAB ANALYTICS
- 9.4.1.1 Proteomic analysis
- 9.4.1.1.1 Utilization of proteomes-on-a-chip devices for therapeutic development to drive market
- 9.4.1.2 Genomic analysis
- 9.4.1.2.1 High-throughput, cost-effective genomic analysis enabled by microfluidics
- 9.4.1.3 Cell-based assays
- 9.4.1.3.1 Microfluidic co-cultures enable precise, high-throughput modeling of complex tissues for drug testing and disease research
- 9.4.1.4 Capillary electrophoresis
- 9.4.1.4.1 Enables high-throughput, precise, and cost-efficient protein and nucleic acid analysis
- 9.4.1.1 Proteomic analysis
- 9.4.2 MICRODISPENSING
- 9.4.2.1 Suitability for low-viscosity applications to support market growth
- 9.4.3 MICROREACTORS
- 9.4.3.1 Growing adoption of continuous flow synthesis in research & development to drive market
- 9.4.1 LAB ANALYTICS
10 MICROFLUIDICS MARKET, BY END USER
- 10.1 INTRODUCTION
- 10.2 HOSPITALS & DIAGNOSTIC CENTERS
- 10.2.1 RISING DEPENDENCE ON RAPID MICROFLUIDIC MOLECULAR DIAGNOSTICS TO DRIVE GROWTH
- 10.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 10.3.1 STRONG ADOPTION OF MICROFLUIDIC TECHNOLOGIES FOR PRECISE FORMULATION, NANOPARTICLE PRODUCTION, AND TOXICITY TESTING TO DRIVE GROWTH
- 10.4 ACADEMIC & RESEARCH INSTITUTES
- 10.4.1 INVESTMENTS IN BIOMEDICAL & LIFE SCIENCE RESEARCH TO DRIVE GROWTH
11 MICROFLUIDICS MARKET, BY REGION
- 11.1 INTRODUCTION
- 11.2 NORTH AMERICA
- 11.2.1 US
- 11.2.1.1 Expansion of applications beyond traditional diagnostics to drive market
- 11.2.2 CANADA
- 11.2.2.1 Government funding and collaborative ecosystems to support growth
- 11.2.1 US
- 11.3 EUROPE
- 11.3.1 GERMANY
- 11.3.1.1 Ongoing investments in semiconductors and microelectronics to drive market
- 11.3.2 FRANCE
- 11.3.2.1 Rising demand for advanced lab-on-chip and organ-on-chip solutions to drive market
- 11.3.3 UK
- 11.3.3.1 Rising cases of chronic diseases and increasing demand for POC testing to boost demand
- 11.3.4 ITALY
- 11.3.4.1 Shift toward cost-efficient microfluidic platforms for diagnostics, environmental testing, and advanced biomedical research to drive market
- 11.3.5 SPAIN
- 11.3.5.1 Increasing demand for accessible point-of-care and lab-on-chip solutions to drive market
- 11.3.6 REST OF EUROPE
- 11.3.1 GERMANY
- 11.4 ASIA PACIFIC
- 11.4.1 CHINA
- 11.4.1.1 Government support and strategic partnerships to drive market
- 11.4.2 JAPAN
- 11.4.2.1 Government support, innovation, and industry-academia collaboration to drive growth
- 11.4.3 INDIA
- 11.4.3.1 Growing biotech startup ecosystem and research from premier institutions to drive market
- 11.4.4 AUSTRALIA
- 11.4.4.1 Innovation ecosystem, R&D strength, and precision engineering to support growth
- 11.4.5 SOUTH KOREA
- 11.4.5.1 Advanced research, global partnerships, and next-gen technologies to drive market
- 11.4.6 REST OF ASIA PACIFIC
- 11.4.1 CHINA
- 11.5 LATIN AMERICA
- 11.5.1 BRAZIL
- 11.5.1.1 Rising investment in healthtech and emphasis on molecular diagnostics to drive market
- 11.5.2 MEXICO
- 11.5.2.1 Growing demand for advanced diagnostics and biotech innovation to drive market
- 11.5.3 REST OF LATIN AMERICA
- 11.5.1 BRAZIL
- 11.6 MIDDLE EAST & AFRICA
- 11.6.1 GCC COUNTRIES
- 11.6.1.1 Disease burden and healthcare modernization to drive market
- 11.6.2 REST OF MIDDLE EAST & AFRICA
- 11.6.1 GCC COUNTRIES
12 COMPETITIVE LANDSCAPE
- 12.1 INTRODUCTION
- 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 12.3 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MICROFLUIDICS MARKET
- 12.4 REVENUE ANALYSIS, 2022-2024
- 12.5 MARKET SHARE ANALYSIS, 2024
- 12.6 RANKING OF KEY MARKET PLAYERS
- 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
- 12.7.1 STARS
- 12.7.2 EMERGING LEADERS
- 12.7.3 PERVASIVE PLAYERS
- 12.7.4 PARTICIPANTS
- 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
- 12.7.5.1 Company footprint
- 12.7.5.2 Region footprint
- 12.7.5.3 Product footprint
- 12.7.5.4 Application footprint
- 12.7.5.5 End user footprint
- 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
- 12.8.1 PROGRESSIVE COMPANIES
- 12.8.2 RESPONSIVE COMPANIES
- 12.8.3 DYNAMIC COMPANIES
- 12.8.4 STARTING BLOCKS
- 12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
- 12.8.5.1 List of key startup/SME players
- 12.8.5.2 Competitive benchmarking of key startups/SMEs
- 12.9 COMPANY VALUATION & FINANCIAL METRICS
- 12.9.1 FINANCIAL METRICS
- 12.9.2 COMPANY VALUATION
- 12.10 BRAND/PRODUCT COMPARATIVE ANALYSIS
- 12.11 COMPETITIVE SCENARIO
- 12.11.1 PRODUCT LAUNCHES & APPROVALS
- 12.11.2 DEALS
- 12.11.3 EXPANSIONS
- 12.11.4 OTHER DEVELOPMENTS
13 COMPANY PROFILES
- 13.1 KEY PLAYERS
- 13.1.1 DANAHER CORPORATION
- 13.1.1.1 Business overview
- 13.1.1.2 Products offered
- 13.1.1.3 Recent developments
- 13.1.1.3.1 Deals
- 13.1.1.3.2 Expansions
- 13.1.1.4 MnM view
- 13.1.1.4.1 Key strengths
- 13.1.1.4.2 Strategic choices
- 13.1.1.4.3 Weaknesses & competitive threats
- 13.1.2 ILLUMINA, INC.
- 13.1.2.1 Business overview
- 13.1.2.2 Products offered
- 13.1.2.3 Recent developments
- 13.1.2.3.1 Product launches
- 13.1.2.3.2 Deals
- 13.1.2.4 MnM view
- 13.1.2.4.1 Key strengths
- 13.1.2.4.2 Strategic choices
- 13.1.2.4.3 Weaknesses & competitive threats
- 13.1.3 BIOMERIEUX
- 13.1.3.1 Business overview
- 13.1.3.2 Products offered
- 13.1.3.3 Recent developments
- 13.1.3.3.1 Product launches/approvals
- 13.1.3.3.2 Deals
- 13.1.3.4 MnM view
- 13.1.3.4.1 Key strengths
- 13.1.3.4.2 Strategic choices
- 13.1.3.4.3 Weaknesses & competitive threats
- 13.1.4 THERMO FISHER SCIENTIFIC INC.
- 13.1.4.1 Business overview
- 13.1.4.2 Products offered
- 13.1.4.3 Recent developments
- 13.1.4.3.1 Product launches/approvals
- 13.1.4.3.2 Deals
- 13.1.4.4 MnM view
- 13.1.4.4.1 Key strengths
- 13.1.4.4.2 Strategic choices
- 13.1.4.4.3 Weaknesses & competitive threats
- 13.1.5 ABBOTT LABORATORIES
- 13.1.5.1 Business overview
- 13.1.5.2 Products offered
- 13.1.5.3 MnM view
- 13.1.5.3.1 Key strengths
- 13.1.5.3.2 Strategic choices
- 13.1.5.3.3 Weaknesses & competitive threats
- 13.1.6 PARKER HANNIFIN CORP
- 13.1.6.1 Business overview
- 13.1.6.2 Products offered
- 13.1.7 SMC CORPORATION
- 13.1.7.1 Business overview
- 13.1.7.2 Products offered
- 13.1.7.3 Recent developments
- 13.1.7.3.1 Product launches
- 13.1.8 IDEX CORPORATION
- 13.1.8.1 Business overview
- 13.1.8.2 Products offered
- 13.1.8.3 Recent developments
- 13.1.8.3.1 Deals
- 13.1.9 FORTIVE
- 13.1.9.1 Business overview
- 13.1.9.2 Products offered
- 13.1.10 REVVITY, INC.
- 13.1.10.1 Business overview
- 13.1.10.2 Products offered
- 13.1.10.3 Recent developments
- 13.1.10.3.1 Deals
- 13.1.11 AGILENT TECHNOLOGIES, INC.
- 13.1.11.1 Business overview
- 13.1.11.2 Products offered
- 13.1.11.3 Recent developments
- 13.1.11.3.1 Product approvals/launches
- 13.1.11.3.2 Deals
- 13.1.11.3.3 Expansions
- 13.1.12 BIO-RAD LABORATORIES, INC.
- 13.1.12.1 Business overview
- 13.1.12.2 Products offered
- 13.1.12.3 Recent developments
- 13.1.12.3.1 Product launches
- 13.1.12.3.2 Deals
- 13.1.13 BECTON, DICKINSON AND COMPANY
- 13.1.13.1 Business overview
- 13.1.13.2 Products offered
- 13.1.13.3 Recent developments
- 13.1.13.3.1 Product launches/approvals
- 13.1.13.3.2 Deals
- 13.1.13.3.3 Expansions
- 13.1.14 F. HOFFMANN-LA ROCHE LTD.
- 13.1.14.1 Business overview
- 13.1.14.2 Products offered
- 13.1.14.3 Recent developments
- 13.1.14.3.1 Product launches/approvals
- 13.1.14.3.2 Deals
- 13.1.15 STANDARD BIOTOOLS
- 13.1.15.1 Business overview
- 13.1.15.2 Products offered
- 13.1.15.3 Recent developments
- 13.1.15.3.1 Product launches/approvals
- 13.1.15.3.2 Deals
- 13.1.16 QUIDELORTHO CORPORATION
- 13.1.16.1 Business overview
- 13.1.16.2 Products offered
- 13.1.16.3 Recent developments
- 13.1.16.3.1 Product approvals
- 13.1.16.3.2 Deals
- 13.1.16.3.3 Expansions
- 13.1.17 AIGNEP S.P.A.
- 13.1.17.1 Business overview
- 13.1.17.2 Products offered
- 13.1.17.3 Recent developments
- 13.1.17.3.1 Deals
- 13.1.18 DOLOMITE MICROFLUIDICS
- 13.1.18.1 Business overview
- 13.1.18.2 Products offered
- 13.1.18.3 Recent developments
- 13.1.18.3.1 Product launches
- 13.1.18.3.2 Deals
- 13.1.18.3.3 Other developments
- 13.1.19 ELVEFLOW
- 13.1.19.1 Business overview
- 13.1.19.2 Products offered
- 13.1.1 DANAHER CORPORATION
- 13.2 OTHER PLAYERS
- 13.2.1 NANOSTRING TECHNOLOGIES
- 13.2.2 INNOVATIVE BIOCHIPS, LLC
- 13.2.3 FLUIDIC ANALYTICS
- 13.2.4 HORIBA
- 13.2.5 MICRONIT B.V.
- 13.2.6 EMULATE, INC.
- 13.2.7 SPHERE BIO
- 13.2.8 ZEON CORPORATION
- 13.2.9 QIAGEN N.V.
14 RESEARCH METHODOLOGY
- 14.1 RESEARCH DATA
- 14.2 RESEARCH DESIGN
- 14.2.1 SECONDARY RESEARCH
- 14.2.1.1 Objectives of secondary research
- 14.2.1.2 Key data from secondary sources
- 14.2.2 PRIMARY RESEARCH
- 14.2.2.1 Objectives of primary research
- 14.2.2.2 Key industry insights
- 14.2.1 SECONDARY RESEARCH
- 14.3 MARKET SIZE ESTIMATION METHODOLOGY
- 14.3.1 BOTTOM-UP APPROACH
- 14.3.1.1 Approach 1: Company revenue estimation approach
- 14.3.1.2 Approach 2: Customer-based market estimation
- 14.3.1.3 Approach 3: Primary interviews
- 14.3.2 TOP-DOWN APPROACH
- 14.3.1 BOTTOM-UP APPROACH
- 14.4 MARKET BREAKDOWN AND DATA TRIANGULATION
- 14.5 MARKET SHARE ASSESSMENT
- 14.6 RESEARCH ASSUMPTIONS
- 14.7 RESEARCH LIMITATIONS
- 14.8 RISK ASSESSMENT
15 APPENDIX
- 15.1 DISCUSSION GUIDE
- 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 15.3 CUSTOMIZATION OPTIONS
- 15.4 RELATED REPORTS
- 15.5 AUTHOR DETAILS
Product Code: AST 7541
List of Tables
- TABLE 1 MICROFLUIDICS MARKET: INCLUSIONS AND EXCLUSIONS
- TABLE 2 MICROFLUIDICS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
- TABLE 3 DIFFERENT FABRICATION MATERIALS USED
- TABLE 4 COMMERCIAL MICROFLUIDIC PCR ASSAYS FOR TB
- TABLE 5 COMPARISON OF KEY MATERIALS USED IN MICROFLUIDIC DEVICES
- TABLE 6 MICROFLUIDICS MARKET: UNMET NEEDS
- TABLE 7 STRATEGIC MOVES BY TIER 1, TIER 2, AND TIER 3 PLAYERS IN MICROFLUIDICS MARKET
- TABLE 8 MICROFLUIDICS MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2022-2024
- TABLE 9 KEY COMPANIES IMPLEMENTING AI/GENAI IN MICROFLUIDICS MARKET
- TABLE 10 US: CLASSIFICATION OF MICROFLUIDICS TECHNOLOGY-ASSOCIATED DIAGNOSTIC DEVICES
- TABLE 11 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION
- TABLE 12 EUROPE: CLASSIFICATION OF MICROFLUIDICS ASSOCIATED WITH IVD DEVICES
- TABLE 13 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION
- TABLE 14 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION
- TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 18 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 19 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MICROFLUIDIC COMPONENTS, BY MATERIAL
- TABLE 21 KEY BUYING CRITERIA FOR MICROFLUIDIC COMPONENTS, BY MATERIAL
- TABLE 22 MICROFLUIDICS MARKET: UNMET NEED ANALYSIS
- TABLE 23 MICROFLUIDICS MARKET: IMPACT OF PORTER'S FIVE FORCES
- TABLE 24 NORTH AMERICA: MACROECONOMIC OUTLOOK
- TABLE 25 EUROPE: MACROECONOMIC OUTLOOK
- TABLE 26 ASIA PACIFIC: MACROECONOMIC INDICATORS
- TABLE 27 LATIN AMERICA: MACROECONOMIC OUTLOOK
- TABLE 28 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
- TABLE 29 MICROFLUIDICS MARKET: ROLE IN ECOSYSTEM
- TABLE 30 AVERAGE SELLING PRICE RANGE OF MICROFLUIDICS COMPONENTS, BY REGION, 2023-2025 (USD THOUSAND)
- TABLE 31 AVERAGE SELLING PRICE TREND OF MICROFLUIDIC COMPONENTS, BY KEY PLAYERS, 2024 (USD)
- TABLE 32 IMPORT DATA FOR HS CODE 3822, BY COUNTRY, 2020-2024 (USD THOUSAND)
- TABLE 33 EXPORT DATA FOR HS CODE 3822, BY COUNTRY, 2020-2024 (USD THOUSAND)
- TABLE 34 MICROFLUIDICS MARKET: KEY CONFERENCES & EVENTS (2026-2027)
- TABLE 35 CASE STUDY 1: MULTIPLEX MICROFLUIDIC CIRCUIT FOR BLOOD VESSEL-ON-A-CHIP PERFUSION USING FLOWEZ
- TABLE 36 CASE STUDY 2: MICROFLUIDIC SYSTEM FOR ROBOTIC HAND PLAYING NINTENDO
- TABLE 37 CASE STUDY 3: 3D-PRINTED MICROFLUIDIC DEVICES USING POLYJET TECHNOLOGY
- TABLE 38 US ADJUSTED RECIPROCAL TARIFF RATES
- TABLE 39 TARIFF-INDUCED PRICE INCREASES FOR HEALTHCARE PRODUCTS
- TABLE 40 MICROFLUIDICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 41 MICROFLUIDICS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 42 MICROFLUIDICS-BASED DEVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 43 MICROFLUIDICS-BASED DEVICES MARKET, BY DEVICE, 2023-2030 (USD MILLION)
- TABLE 44 PCR SYSTEMS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 45 MICROFLUIDIC CAPILLARY ELECTROPHORESIS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 46 NEXT-GENERATION SEQUENCING SYSTEMS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 47 DROPLET & PARTICLE PRODUCTION SYSTEMS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 48 OTHER DEVICES MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 49 MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 50 MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 51 MICROFLUIDIC CHIPS OFFERED BY KEY PLAYERS
- TABLE 52 MICROFLUIDIC CHIPS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 53 FLOW & PRESSURE SENSORS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 54 FLOW & PRESSURE CONTROLLERS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 55 MICROFLUIDIC VALVES MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 56 MICROPUMPS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 57 MICRONEEDLES OFFERED BY KEY PLAYERS
- TABLE 58 MICRONEEDLES MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 59 OTHER MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 60 MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023-2030 (USD MILLION)
- TABLE 61 MATERIAL-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 62 SILICON-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 63 PMMA-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 64 PDMS-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 65 COC-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 66 GLASS-BASED MICROFLUIDIC COMPONENTS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 67 OTHER MATERIALS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 68 MICROFLUIDICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 69 MICROFLUIDICS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 70 MICROFLUIDICS MARKET FOR IVD APPLICATION, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 71 MICROFLUIDICS MARKET FOR IVD APPLICATION, BY REGION, 2023-2030 (USD MILLION)
- TABLE 72 MICROFLUIDICS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 73 MICROFLUIDICS MARKET FOR POCT, BY REGION, 2023-2030 (USD MILLION)
- TABLE 74 MICROFLUIDICS MARKET FOR VETERINARY DIAGNOSTICS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 75 MICROFLUIDICS MARKET FOR THERAPEUTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 76 MICROFLUIDICS MARKET FOR THERAPEUTICS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 77 COMPARISON OF MICROFLUIDIC VS. TRADITIONAL API ENCAPSULATION
- TABLE 78 MICROFLUIDICS MARKET FOR DRUG DELIVERY, BY REGION, 2023-2030 (USD MILLION)
- TABLE 79 OVERVIEW OF WEARABLE MICROFLUIDIC PLATFORMS ACROSS BIOFLUIDS: TARGETS, APPLICATIONS, DETECTION STRATEGIES, AND TRANSLATIONAL STATUS
- TABLE 80 MICROFLUIDICS MARKET FOR WEARABLE DEVICES, BY REGION, 2023-2030 (USD MILLION)
- TABLE 81 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 82 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY REGION, 2023-2030 (USD MILLION)
- TABLE 83 MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 84 MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 85 MICROFLUIDICS MARKET FOR PROTEOMIC ANALYSIS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 86 MICROFLUIDICS MARKET FOR GENOMIC ANALYSIS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 87 KEY ORGAN-ON-CHIP APPLICATIONS
- TABLE 88 MICROFLUIDICS MARKET FOR CELL-BASED ASSAYS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 89 MICROFLUIDICS MARKET FOR CAPILLARY ELECTROPHORESIS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 90 MICROFLUIDICS MARKET FOR MICRODISPENSING, BY REGION, 2023-2030 (USD MILLION)
- TABLE 91 MICROFLUIDICS MARKET FOR MICROREACTORS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 92 MICROFLUIDICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 93 MICROFLUIDICS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 94 MICROFLUIDICS MARKET FOR HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2023-2030 (USD MILLION)
- TABLE 95 MICROFLUIDICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2023-2030 (USD MILLION)
- TABLE 96 LEADING MICROFLUIDICS RESEARCH INSTITUTES, BY AREA OF INTEREST
- TABLE 97 MICROFLUIDICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2023-2030 (USD MILLION)
- TABLE 98 MICROFLUIDICS MARKET, BY REGION, 2023-2030 (USD MILLION)
- TABLE 99 NORTH AMERICA: MICROFLUIDICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 100 NORTH AMERICA: MICROFLUIDICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 101 NORTH AMERICA: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023-2030 (USD MILLION)
- TABLE 102 NORTH AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 103 NORTH AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023-2030 (USD MILLION)
- TABLE 104 NORTH AMERICA: MICROFLUIDICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 105 NORTH AMERICA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 106 NORTH AMERICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 107 NORTH AMERICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 108 NORTH AMERICA: MICROFLUIDICS MARKET FOR THERAPEUTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 109 NORTH AMERICA: MICROFLUIDICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 110 US: MICROFLUIDICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 111 US: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023-2030 (USD MILLION)
- TABLE 112 US: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 113 US: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023-2030 (USD MILLION)
- TABLE 114 CANADA: MICROFLUIDICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 115 CANADA: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023-2030 (USD MILLION)
- TABLE 116 CANADA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 117 CANADA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023-2030 (USD MILLION)
- TABLE 118 EUROPE: MICROFLUIDICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 119 EUROPE: MICROFLUIDICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 120 EUROPE: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023-2030 (USD MILLION)
- TABLE 121 EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 122 EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023-2030 (USD MILLION)
- TABLE 123 EUROPE: MICROFLUIDICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 124 EUROPE: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 125 EUROPE: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 126 EUROPE: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 127 EUROPE: MICROFLUIDICS MARKET FOR THERAPEUTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 128 EUROPE: MICROFLUIDICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 129 GERMANY: MICROFLUIDICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 130 GERMANY: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023-2030 (USD MILLION)
- TABLE 131 GERMANY: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 132 GERMANY: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023-2030 (USD MILLION)
- TABLE 133 FRANCE: MICROFLUIDICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 134 FRANCE: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023-2030 (USD MILLION)
- TABLE 135 FRANCE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 136 FRANCE: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023-2030 (USD MILLION)
- TABLE 137 UK: MICROFLUIDICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 138 UK: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023-2030 (USD MILLION)
- TABLE 139 UK: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 140 UK: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023-2030 (USD MILLION)
- TABLE 141 ITALY: MICROFLUIDICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 142 ITALY: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023-2030 (USD MILLION)
- TABLE 143 ITALY: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 144 ITALY: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023-2030 (USD MILLION)
- TABLE 145 SPAIN: MICROFLUIDICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 146 SPAIN: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023-2030 (USD MILLION)
- TABLE 147 SPAIN: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 148 SPAIN: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023-2030 (USD MILLION)
- TABLE 149 REST OF EUROPE: MICROFLUIDICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 150 REST OF EUROPE: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023-2030 (USD MILLION)
- TABLE 151 REST OF EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 152 REST OF EUROPE: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023-2030 (USD MILLION)
- TABLE 153 ASIA PACIFIC: MICROFLUIDICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 154 ASIA PACIFIC: MICROFLUIDICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 155 ASIA PACIFIC: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023-2030 (USD MILLION)
- TABLE 156 ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 157 ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023-2030 (USD MILLION)
- TABLE 158 ASIA PACIFIC: MICROFLUIDICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 159 ASIA PACIFIC: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 160 ASIA PACIFIC: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 161 ASIA PACIFIC: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 162 ASIA PACIFIC: MICROFLUIDICS MARKET FOR THERAPEUTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 163 ASIA PACIFIC: MICROFLUIDICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 164 CHINA: MICROFLUIDICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 165 CHINA: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023-2030 (USD MILLION)
- TABLE 166 CHINA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 167 CHINA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023-2030 (USD MILLION)
- TABLE 168 JAPAN: MICROFLUIDICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 169 JAPAN: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023-2030 (USD MILLION)
- TABLE 170 JAPAN: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 171 JAPAN: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023-2030 (USD MILLION)
- TABLE 172 INDIA: MICROFLUIDICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 173 INDIA: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023-2030 (USD MILLION)
- TABLE 174 INDIA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 175 INDIA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023-2030 (USD MILLION)
- TABLE 176 AUSTRALIA: MICROFLUIDICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 177 AUSTRALIA: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023-2030 (USD MILLION)
- TABLE 178 AUSTRALIA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 179 AUSTRALIA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023-2030 (USD MILLION)
- TABLE 180 SOUTH KOREA: MICROFLUIDICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 181 SOUTH KOREA: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023-2030 (USD MILLION)
- TABLE 182 SOUTH KOREA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 183 SOUTH KOREA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023-2030 (USD MILLION)
- TABLE 184 REST OF ASIA PACIFIC: MICROFLUIDICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 185 REST OF ASIA PACIFIC: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023-2030 (USD MILLION)
- TABLE 186 REST OF ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 187 REST OF ASIA PACIFIC: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023-2030 (USD MILLION)
- TABLE 188 LATIN AMERICA: MICROFLUIDICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 189 LATIN AMERICA: MICROFLUIDICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 190 LATIN AMERICA: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023-2030 (USD MILLION)
- TABLE 191 LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 192 LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023-2030 (USD MILLION)
- TABLE 193 LATIN AMERICA: MICROFLUIDICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 194 LATIN AMERICA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 195 LATIN AMERICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 196 LATIN AMERICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 197 LATIN AMERICA: MICROFLUIDICS MARKET FOR THERAPEUTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 198 LATIN AMERICA: MICROFLUIDICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 199 BRAZIL: MICROFLUIDICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 200 BRAZIL: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023-2030 (USD MILLION)
- TABLE 201 BRAZIL: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 202 BRAZIL: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023-2030 (USD MILLION)
- TABLE 203 MEXICO: MICROFLUIDICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 204 MEXICO: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023-2030 (USD MILLION)
- TABLE 205 MEXICO: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 206 MEXICO: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023-2030 (USD MILLION)
- TABLE 207 REST OF LATIN AMERICA: MICROFLUIDICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 208 REST OF LATIN AMERICA: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023-2030 (USD MILLION)
- TABLE 209 REST OF LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 210 REST OF LATIN AMERICA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023-2030 (USD MILLION)
- TABLE 211 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
- TABLE 212 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 213 MIDDLE EAST & AFRICA: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023-2030 (USD MILLION)
- TABLE 214 MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 215 MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023-2030 (USD MILLION)
- TABLE 216 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY APPLICATION, 2023-2030 (USD MILLION)
- TABLE 217 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR IVD APPLICATIONS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 218 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR PHARMACEUTICAL & LIFE SCIENCE RESEARCH, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 219 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR LAB ANALYTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 220 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET FOR THERAPEUTICS, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 221 MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY END USER, 2023-2030 (USD MILLION)
- TABLE 222 GCC COUNTRIES: MICROFLUIDICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 223 GCC COUNTRIES: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023-2030 (USD MILLION)
- TABLE 224 GCC COUNTRIES: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 225 GCC COUNTRIES: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023-2030 (USD MILLION)
- TABLE 226 REST OF MIDDLE EAST & AFRICA: MICROFLUIDICS MARKET, BY PRODUCT, 2023-2030 (USD MILLION)
- TABLE 227 REST OF MIDDLE EAST & AFRICA: MICROFLUIDIC-BASED DEVICES MARKET, BY DEVICE, 2023-2030 (USD MILLION)
- TABLE 228 REST OF MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET, BY TYPE, 2023-2030 (USD MILLION)
- TABLE 229 REST OF MIDDLE EAST & AFRICA: MICROFLUIDIC COMPONENTS MARKET, BY MATERIAL, 2023-2030 (USD MILLION)
- TABLE 230 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
- TABLE 231 MICROFLUIDICS MARKET: DEGREE OF COMPETITION
- TABLE 232 MICROFLUIDICS MARKET: REGION FOOTPRINT
- TABLE 233 MICROFLUIDICS MARKET: PRODUCT FOOTPRINT
- TABLE 234 MICROFLUIDICS MARKET: APPLICATION FOOTPRINT
- TABLE 235 MICROFLUIDICS MARKET: END USER FOOTPRINT
- TABLE 236 MICROFLUIDICS MARKET: LIST OF KEY STARTUP/SME PLAYERS
- TABLE 237 MICROFLUIDICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
- TABLE 238 MICROFLUIDICS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022-NOVEMBER 2025
- TABLE 239 MICROFLUIDICS MARKET: DEALS, JANUARY 2022-NOVEMBER 2025
- TABLE 240 MICROFLUIDICS MARKET: EXPANSIONS, JANUARY 2022-NOVEMBER 2025
- TABLE 241 MICROFLUIDICS MARKET: OTHER DEVELOPMENTS, JANUARY 2022-NOVEMBER 2025
- TABLE 242 DANAHER CORPORATION: COMPANY OVERVIEW
- TABLE 243 DANAHER CORPORATION: PRODUCTS OFFERED
- TABLE 244 DANAHER CORPORATION: DEALS
- TABLE 245 DANAHER CORPORATION: EXPANSIONS
- TABLE 246 ILLUMINA, INC.: COMPANY OVERVIEW
- TABLE 247 ILLUMINA, INC.: PRODUCTS OFFERED
- TABLE 248 ILLUMINA, INC.: PRODUCT LAUNCHES
- TABLE 249 ILLUMINA, INC.: DEALS
- TABLE 250 BIOMERIEUX: COMPANY OVERVIEW
- TABLE 251 BIOMERIEUX: PRODUCTS OFFERED
- TABLE 252 BIOMERIEUX: PRODUCT LAUNCHES/APPROVALS
- TABLE 253 BIOMERIEUX: DEALS
- TABLE 254 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
- TABLE 255 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
- TABLE 256 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES/APPROVALS
- TABLE 257 THERMO FISHER SCIENTIFIC INC.: DEALS
- TABLE 258 ABBOTT LABORATORIES: COMPANY OVERVIEW
- TABLE 259 ABBOTT LABORATORIES: PRODUCTS OFFERED
- TABLE 260 PARKER HANNIFIN CORP: COMPANY OVERVIEW
- TABLE 261 PARK HANNIFIN CORP: PRODUCTS OFFERED
- TABLE 262 SMC CORPORATION: COMPANY OVERVIEW
- TABLE 263 SMC CORPORATION: PRODUCTS OFFERED
- TABLE 264 SMC CORPORATION: PRODUCT LAUNCHES
- TABLE 265 IDEX CORPORATION: COMPANY OVERVIEW
- TABLE 266 IDEX CORPORATION: PRODUCTS OFFERED
- TABLE 267 IDEX CORPORATION: DEALS
- TABLE 268 FORTIVE: COMPANY OVERVIEW
- TABLE 269 FORTIVE: PRODUCTS OFFERED
- TABLE 270 REVVITY, INC.: COMPANY OVERVIEW
- TABLE 271 REVVITY, INC.: PRODUCTS OFFERED
- TABLE 272 REVVITY, INC.: DEALS
- TABLE 273 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW
- TABLE 274 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
- TABLE 275 AGILENT TECHNOLOGIES, INC. : PRODUCT APPROVALS/LAUNCHES
- TABLE 276 AGILENT TECHNOLOGIES, INC.: DEALS
- TABLE 277 AGILENT TECHNOLOGIES, INC.: EXPANSIONS
- TABLE 278 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
- TABLE 279 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED
- TABLE 280 BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES
- TABLE 281 BIO-RAD LABORATORIES, INC.: DEALS
- TABLE 282 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
- TABLE 283 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED
- TABLE 284 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES/APPROVALS,
- TABLE 285 BECTON, DICKINSON AND COMPANY: DEALS
- TABLE 286 BECTON, DICKINSON AND COMPANY: EXPANSIONS
- TABLE 287 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
- TABLE 288 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED
- TABLE 289 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES/APPROVALS,
- TABLE 290 F. HOFFMANN-LA ROCHE LTD.: DEALS
- TABLE 291 STANDARD BIOTOOLS: COMPANY OVERVIEW
- TABLE 292 STANDARD BIOTOOLS: PRODUCTS OFFERED
- TABLE 293 STANDARD BIOTOOLS: PRODUCT LAUNCHES/APPROVALS
- TABLE 294 STANDARD BIOTOOLS: DEALS
- TABLE 295 QUIDELORTHO CORPORATION: COMPANY OVERVIEW
- TABLE 296 QUIDELORTHO CORPORATION: PRODUCTS OFFERED
- TABLE 297 QUIDELORTHO CORPORATION: PRODUCT APPROVALS
- TABLE 298 QUIDELORTHO CORPORATION: DEALS
- TABLE 299 QUIDELORTHO CORPORATION: EXPANSIONS
- TABLE 300 AIGNEP S.P.A.: COMPANY OVERVIEW
- TABLE 301 AIGNEP S.P.A.: PRODUCTS OFFERED
- TABLE 302 AIGNEP S.P.A.: DEALS
- TABLE 303 DOLOMITE MICROFLUIDICS: COMPANY OVERVIEW
- TABLE 304 DOLOMITE MICROFLUIDICS: PRODUCTS OFFERED
- TABLE 305 DOLOMITE MICROFLUIDICS: PRODUCT LAUNCHES
- TABLE 306 DOLOMITE MICROFLUIDICS: DEALS
- TABLE 307 DOLOMITE MICROFLUIDICS: OTHER DEVELOPMENTS
- TABLE 308 ELVEFLOW: COMPANY OVERVIEW
- TABLE 309 ELVEFLOW: PRODUCTS OFFERED
- TABLE 310 NANOSTRING TECHNOLOGIES: COMPANY OVERVIEW
- TABLE 311 INNOVATIVE BIOCHIPS, LLC: COMPANY OVERVIEW
- TABLE 312 FLUIDIC ANALYTICS: COMPANY OVERVIEW
- TABLE 313 HORIBA: COMPANY OVERVIEW
- TABLE 314 MICRONIT B.V.: COMPANY OVERVIEW
- TABLE 315 EMULATE, INC.: COMPANY OVERVIEW
- TABLE 316 SPHERE BIO: COMPANY OVERVIEW
- TABLE 317 ZEON CORPORATION: COMPANY OVERVIEW
- TABLE 318 QIAGEN N.V.: COMPANY OVERVIEW
List of Figures
- FIGURE 1 MICROFLUIDICS MARKET SEGMENTATION
- FIGURE 2 MARKET SCENARIO
- FIGURE 3 GLOBAL MICROFLUIDICS MARKET, 2022-2030
- FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MICROFLUIDICS MARKET, 2020-2025
- FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF MICROFLUIDICS MARKET
- FIGURE 6 HIGH-GROWTH SEGMENTS IN MICROFLUIDICS MARKET, 2025-2030
- FIGURE 7 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN MICROFLUIDICS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD
- FIGURE 8 RISING ADOPTION OF LAB-ON-A-CHIP TECHNOLOGIES TO DRIVE MARKET
- FIGURE 9 NORTH AMERICA TO COMMAND LARGEST MARKET SHARE IN 2030
- FIGURE 10 NORTH AMERICA AND HOSPITALS & DIAGNOSTIC CENTERS ACCOUNTED FOR LARGEST MARKET SHARES IN 2024
- FIGURE 11 CHINA TO REGISTER FASTEST GROWTH FROM 2025 TO 2030
- FIGURE 12 MICROFLUIDICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
- FIGURE 13 PATENT ANALYSIS FOR MICROFLUIDICS MARKET, JANUARY 2015-NOVEMBER 2025
- FIGURE 14 KEY AI USE CASES IN MICROFLUIDICS MARKET
- FIGURE 15 US: REGULATORY PROCESS FOR TESTING DEVICES ASSOCIATED WITH MICROFLUIDICS TECHNOLOGY
- FIGURE 16 CANADA: REGULATORY PROCESS FOR MICROFLUIDICS-ASSOCIATED IVD DEVICES
- FIGURE 17 EUROPE: REGULATORY PROCESS FOR IVD DEVICES
- FIGURE 18 INDIA: REGULATORY PROCESS FOR IVD DEVICES
- FIGURE 19 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS FOR MICROFLUIDIC COMPONENTS, BY MATERIAL
- FIGURE 20 KEY BUYING CRITERIA FOR MICROFLUIDIC COMPONENTS, BY MATERIAL
- FIGURE 21 MICROFLUIDICS MARKET: UNMET NEED ANALYSIS
- FIGURE 22 MICROFLUIDICS MARKET: PORTER'S FIVE FORCES ANALYSIS
- FIGURE 23 MICROFLUIDICS MARKET: VALUE CHAIN ANALYSIS
- FIGURE 24 MICROFLUIDICS MARKET: ECOSYSTEM ANALYSIS
- FIGURE 25 AVERAGE SELLING PRICE TREND OF MICROFLUIDIC COMPONENTS, BY REGION, 2023-2025 (USD)
- FIGURE 26 AVERAGE SELLING PRICE TREND OF MICROFLUIDIC COMPONENTS, BY KEY PLAYERS, 2024 (USD)
- FIGURE 27 MICROFLUIDICS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
- FIGURE 28 MICROFLUIDICS MARKET: FUNDING AND NUMBER OF DEALS, 2019-2023 (USD MILLION)
- FIGURE 29 NUMBER OF DEALS IN MICROFLUIDICS MARKET, BY KEY PLAYERS, 2019-2023
- FIGURE 30 VALUE OF DEALS IN MICROFLUIDICS MARKET, BY KEY PLAYERS, 2019-2023 (USD)
- FIGURE 31 NORTH AMERICA: MICROFLUIDICS MARKET SNAPSHOT
- FIGURE 32 ASIA PACIFIC: MICROFLUIDICS MARKET SNAPSHOT
- FIGURE 33 REVENUE ANALYSIS OF KEY PLAYERS IN MICROFLUIDICS MARKET (2022-2024)
- FIGURE 34 MARKET SHARE ANALYSIS OF KEY PLAYERS IN MICROFLUIDICS MARKET (2024)
- FIGURE 35 RANKING OF KEY PLAYERS IN MICROFLUIDICS MARKET, 2024
- FIGURE 36 MICROFLUIDICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
- FIGURE 37 MICROFLUIDICS MARKET: COMPANY FOOTPRINT
- FIGURE 38 MICROFLUIDICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
- FIGURE 39 EV/EBITDA OF KEY VENDORS, 2025
- FIGURE 40 YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025
- FIGURE 41 MICROFLUIDICS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
- FIGURE 42 DANAHER CORPORATION: COMPANY SNAPSHOT
- FIGURE 43 ILLUMINA, INC.: COMPANY SNAPSHOT
- FIGURE 44 BIOMERIEUX: COMPANY SNAPSHOT
- FIGURE 45 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
- FIGURE 46 ABBOTT LABORATORIES: COMPANY SNAPSHOT
- FIGURE 47 PARKER HANNIFIN CORP: COMPANY SNAPSHOT
- FIGURE 48 SMC CORPORATION: COMPANY SNAPSHOT (2024)
- FIGURE 49 IDEX CORPORATION: COMPANY SNAPSHOT
- FIGURE 50 FORTIVE: COMPANY SNAPSHOT
- FIGURE 51 REVVITY, INC.: COMPANY SNAPSHOT
- FIGURE 52 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
- FIGURE 53 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
- FIGURE 54 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
- FIGURE 55 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
- FIGURE 56 STANDARD BIOTOOLS: COMPANY SNAPSHOT
- FIGURE 57 QUIDELORTHO CORPORATION: COMPANY SNAPSHOT
- FIGURE 58 MICROFLUIDICS MARKET: RESEARCH DATA
- FIGURE 59 MICROFLUIDICS MARKET: RESEARCH DESIGN
- FIGURE 60 PRIMARY SOURCES
- FIGURE 61 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
- FIGURE 62 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
- FIGURE 63 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
- FIGURE 64 MICROFLUIDICS MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
- FIGURE 65 MICROFLUIDICS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
- FIGURE 66 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
- FIGURE 67 DATA TRIANGULATION
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.